CEACAM5 and systemic mastocytosis: Only one study in the English literature assesses potential prognostic factors for long-term survival in patients with splenectomies for SM of CRC origin showing no impact on survival for the age, gender, primary tumor location, Duke’s stage, SM size, synchronous/metachronous pattern, or CEA serum level in this study [17].